<DOC>
	<DOC>NCT00734097</DOC>
	<brief_summary>The purpose of this study is to assess how patients with gastro-oesophageal reflux disease (heartburn) who are currently receiving treatment with a proton pump inhibitor but are still experiencing symptoms will benefit from a change in treatment.</brief_summary>
	<brief_title>A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Persisting symptoms of GORD despite previous treatment with a full dose proton pump inhibitor informed consent over 18 years of age Current course of Proton Pump inhibitor treatment for more than 8 weeks prior to enrolment in the study More than 1 other course of PPI treatment in the previous 12 month previous use of esomeprazole presence of alarm symptoms</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>heartburn</keyword>
	<keyword>reflux</keyword>
	<keyword>proton</keyword>
	<keyword>pump</keyword>
	<keyword>inhibitor</keyword>
</DOC>